Schols [37]# | 213, numbers per treatment arm and sex not reported | | Nandrolone decanoate 50 mg (M) or 25 mg (F) every 2 weeks for 8 weeks | Endurance training: 8 weeks, 5 days·week−1 | FFM (BIA), weight, PI,max, arm circumference | FFM and PI,max (NN versus P) |
Ferreira [38] | 10 M/7 M | BMI <20 kg·m−2, PI,max <60% pred | Testosterone 250 mg at start then stanozolol 12 mg·day−1 orally for 27 weeks | 0–9 weeks: none, 9–18 weeks: inspiratory muscle training, 18–27 weeks: endurance training | BMI, LBM (DEXA), extremity circumference, PI,max, 6MWD, V′O2,max | LBM 3/0 kg* Thigh circumference 2/0%* Other ns |
Creutzberg [39] | 33 M/30 M | <70 yrs, PO2 >7.3 kPa | Nandrolone decanoate 50 mg every 2 weeks for 8 weeks | Endurance training: 8 weeks, 5 days·week−1 | FFM (deuterium method), isometric leg strength, PI,max, SGRQ, Wmax and V′O2,max | FFM 1.7/0.3 kg* Other ns Post hoc oral corticosteroid users larger effects on Wmax and PI,max |
Casaburi [40]¶ | 12 M/11 M | FEV1 <60% pred, serum testosterone <400 ng·dL−1 | Testosterone enanthate 100 mg once a week for 10 weeks | Resistance training: 10 weeks, 3 days·week−1 | LBM (DEXA), 1RM leg press | Total LBM 3.3/0.2 kg Leg lean 1.4/0.5 kg* 1RM 27/17%* |
Svartberg [41] | 15 M/14 M | FEV1 <60% pred | Testosterone enanthate 250 mg every 4 weeks for 29 weeks | None | 6MWD, FFM (DEXA), SGRQ, sexual QoL questionnaire | FFM 1.1/–0.8* Sexual QoL improved Other outcomes ns |
Sharma [42] | 8 (5 M and 3 F)/8 (4 M and 4 F) | FEV1 <50% pred | Nandrolone decanoate 50 mg (M) or 25 mg (F) every 2 weeks for 16 weeks | Resistance/endurance training: 16 weeks, 3 days·week−1 unsupervised | CRQ, LBM (DEXA), 6MWD | ns |